Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HNF4A | P41235 | 1/20 | 0.63 |
| ▸ | MYC | P01106 | 1/20 | 0.56 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.53 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | FABP3 | P05413 | 1/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.53 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.53 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28429025 | 0.93 | HNF4A (0.56) | HNF4AMYCPDCD1CD274FABP4 | |
| SCHEMBL27499893 | 0.92 | HNF4A (0.59) | HNF4AMYCPDCD1CD274FABP4 | |
| SCHEMBL5046158 | 0.87 | MYC (0.59) | HNF4AMYCPTGER1SMN1; SMN2MEN1 | |
| SCHEMBL6440453 | 0.87 | HSD17B10 (0.53) | HNF4AMYCFABP4FABP3FABP5 | |
| Phthalic Acid SCHEMBL29032500 | 0.87 | MYC (0.61) | HNF4AMYCPDCD1CD274FABP4 | |
| SCHEMBL13065950 | 0.86 | PDCD1 (0.52) | HNF4AMYCPDCD1CD274FABP4 | |
| SCHEMBL24665235 | 0.85 | SLC6A4 (0.53) | HNF4AMYCPTGER1SMN1; SMN2ALDH1A1 | |
| SCHEMBL16247703 | 0.85 | AKR1C2 (0.51) | HNF4AMYCPTGER1SMN1; SMN2MEN1 | |
| Biphenyl SCHEMBL27319576 | 0.85 | NPC1 (0.60) | HNF4AMYCFABP4MEN1KMT2A | |
| SCHEMBL30034930 | 0.85 | BCAT2 (0.69) | HNF4AMYCPDCD1CD274BCAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-108997164-A | 2- methyl -3- phenylbenzohydrazide and its synthetic method | 安康学院 | 2018-12-14 | — | — | CN | claimed |
| CN-108947866-A | N-(2- methyl -3- Phenylbenzoyl)-N '-tertiary butyl hydrazine and its synthetic method | 安康学院 | 2018-12-07 | — | — | CN | claimed |
| CN-106715557-A9 | Monobenzoate analogs useful as plasticizers in plastisol compositions | 艾默罗德卡拉玛化学品公司 | 2017-08-25 | — | — | CN | claimed |
| CN-106715557-A | Monobenzoate analogs useful as plasticizers in plastisol compositions | 艾默罗德卡拉玛化学品公司 | 2017-05-24 | — | — | CN | claimed |
| CN-101981003-B | Amide compounds, compositions and uses thereof | RENOVIS INC | 2014-07-02 | — | — | CN | claimed |
| CN-101981003-A | Amide compounds, compositions and uses thereof | RENOVIS INC | 2011-02-23 | — | — | CN | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| CN-101135683-A | Bifenthrin antigen, antibody and uses thereof | UNIV NANJING AGRICULTURAL (CN) | 2008-03-05 | — | — | CN | claimed |
| WO-2001034197-A2 | ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER | ELI LILLY AND COMPANY (US) | 2001-05-17 | — | — | WO | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | disclosed |
| US-12187811-B2 | Cyclic peptide compound simulating natural product structure, and method for preparation thereof | NANKAI UNIVERSITY (CN) | 2025-01-07 | — | — | US | disclosed |
| CN-116041277-B | Phenyl and biphenyl substituted five-membered heterocyclic compound, preparation method, pharmaceutical composition and application thereof | 中国药科大学 | 2024-11-01 | — | — | CN | disclosed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | disclosed |
| WO-2004080376-A2 | HYDROXYETHYLAMINE COMPOUNDS HAVING ASP2 INHIBITORY ACTIVITY FOR THE TREATMENT OF ALZHEIMER’S DISEASE | GLAXO GROUP LIMITED (GB) | 2004-09-23 | — | — | WO | disclosed |
| WO-2003101928-A1 | NOVEL LIGANDS THAT ARE INHIBITORS OF THE RAR RECEPTORS, PROCESS FOR PREPARING THEM AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS | GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) | 2003-12-11 | — | — | WO | disclosed |
| WO-2003097617-A1 | CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2003-11-27 | — | — | WO | disclosed |
| WO-2001034198-A2 | ONCOLYTIC COMBINATIONS FOR THE TREATMENT OF CANCER | ELI LILLY AND COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |
| CN-1120838-A | Heterocyclic derivatives in the treatment of ischaemia and related diseases | SYNTEX PHARMA LTD (GB) | 1996-04-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12187811-B2 | Cyclic peptide compound simulating natural product structure, and method for preparation thereof | VIP, PTMS, NPPA | HNF4A 3216/4885MYC 1029/4885PDCD1 122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.